Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Keytruda/Inlyta combo scores FDA approval in advanced kidney cancer

pharmafilesApril 24, 2019

Tag: FDA , carcinoma , approval

PharmaSources Customer Service